Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
2.110
-0.010 (-0.47%)
Nov 22, 2024, 4:00 PM EST - Market closed
Akoya Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 105 | 239 | 363 | 570 | - | - |
| Market Cap Growth | -40.84% | -34.07% | -36.24% | - | - | - |
| Enterprise Value | 150 | 236 | 347 | 482 | - | - |
| Last Close Price | 2.11 | 4.88 | 9.57 | 15.31 | - | - |
| PS Ratio | 1.20 | 2.48 | 4.85 | 10.37 | - | - |
| PB Ratio | 7.66 | 4.45 | 6.20 | 4.69 | - | - |
| P/TBV Ratio | - | 13.23 | 17.92 | 6.95 | - | - |
| EV/Sales Ratio | 1.73 | 2.44 | 4.64 | 8.78 | - | - |
| Debt / Equity Ratio | 6.23 | 1.59 | 1.29 | 0.27 | 1.94 | 0.72 |
| Asset Turnover | 0.57 | 0.54 | 0.41 | 0.41 | 0.51 | - |
| Inventory Turnover | 1.67 | 2.49 | 2.68 | 3.12 | 3.96 | - |
| Quick Ratio | 1.74 | 2.83 | 2.45 | 4.61 | 1.37 | 1.65 |
| Current Ratio | 2.75 | 3.45 | 3.03 | 5.09 | 1.67 | 1.93 |
| Return on Equity (ROE) | -153.34% | -112.72% | -78.52% | -61.59% | -63.92% | - |
| Return on Assets (ROA) | -18.02% | -19.65% | -22.55% | -17.33% | -8.60% | - |
| Return on Capital (ROIC) | -23.49% | -25.58% | -28.67% | -22.44% | -12.82% | - |
| Earnings Yield | -55.43% | -26.44% | -19.45% | -7.54% | - | - |
| FCF Yield | -46.58% | -22.78% | -16.75% | -7.23% | - | - |
| Buyback Yield / Dilution | -19.11% | -17.72% | -40.34% | -1034.62% | -4.15% | - |
| Total Shareholder Return | -19.11% | -17.72% | -40.34% | -1034.62% | -4.15% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.